Topic Review
Stages in the Evolution of Kidney Damage
Acute kidney injury (AKI) is a major clinical problem associated with increased morbidity and mortality. Despite intensive research, the clinical outcome remains poor, and apart from supportive therapy, no other specific therapy exists. Furthermore, acute kidney injury increases the risk of developing chronic kidney disease (CKD) and end-stage renal disease. 
  • 361
  • 13 Feb 2023
Topic Review
Collagen Treatment
Collagen, the most abundant protein in our bodies, plays a crucial role in maintaining the structural integrity of various tissues and organs. Collagen treatment offers a range of advantages, including antioxidant and anti-inflammatory properties, wound healing support, benefits for hair and nail health, improvement in gut health, support for joint health, skin rejuvenation, and potential support for musculoskeletal disorders and cardiovascular health.
  • 361
  • 11 Oct 2023
Topic Review
Targeted Therapies for Familial Hypercholesterolemia
Several new targeted therapies were developed for familial hypercholesterolemia, and some are being tested to achieve the low-density lipoprotein (LDL)-C goals for high-/very-high-risk familial hypercholesterolemia (FH) patients as recommended by the ESC/EAS 2016–2019 guidelines. The advantage of targeted therapies is that they provide clinicians with the power to practice personalized or precision medicine with the aim of achieving better risk/benefit and cost/effectiveness of therapies.
  • 358
  • 15 Nov 2022
Topic Review
Hepatic LKB1 and NAFLD
Hepatic lipid droplets, expression of AR, and phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) increased in the presence of testosterone. Concurrently, the expression of LKB1, an upstream regulator of AMPK, was increased by testosterone treatment.
  • 356
  • 25 Nov 2021
Topic Review
Novel Oral Anticoagulants
The use of novel oral anticoagulants in patients with impaired renal function or undergoing immunosuppressive therapy is limited due to the risk of drug-to-drug interactions and anticoagulation-related adverse events. Novel oral anticoagulants (NOACs) have been commonly used in patients facing a higher risk of cardiovascular (CV) incidents such as atrial fibrillation (AF) and venous thrombo-embolic events (VTE), successfully decreasing numbers of CV incidents in the general population. The probability of those incidents increases in specific groups of patients, including those with chronic kidney disease (CKD) where the risk of developing AF averages between 19–24%, reaching up to 27% in patients with end-stage kidney disease (ESKD).
  • 356
  • 04 Jul 2022
Topic Review
Writing Therapy
Writing therapy is a form of expressive therapy that uses the act of writing and processing the written word as therapy. Writing therapy posits that writing one's feelings gradually eases feelings of emotional trauma. Writing therapeutically can take place individually or in a group and it can be administered in person with a therapist or remotely through mailing or the Internet. The field of writing therapy includes many practitioners in a variety of settings. The therapy is usually administered by a therapist or counselor. Several interventions exist online. Writing group leaders also work in hospitals with patients dealing with mental and physical illnesses. In university departments they aid student self-awareness and self-development. When administered at a distance, it is useful for those who prefer to remain personally anonymous and are not ready to disclose their most private thoughts and anxieties in a face-to-face situation. As with most forms of therapy, writing therapy is adapted and used to work with a wide range of psychoneurotic issues, including bereavement, desertion and abuse. Many of these interventions take the form of classes where clients write on specific themes chosen by their therapist or counsellor. Assignments may include writing unsent letters to selected individuals, alive or dead, followed by imagined replies from the recipient, or a dialogue with the recovering alcoholic's bottle of alcohol.
  • 356
  • 28 Sep 2022
Topic Review
BCG Vaccination
BCG vaccine has been used for 100 years to prevent tuberculosis. Not all countries, including the United States, adopted the initial World Health Organization recommendation to use BCG. Moreover, many Western countries that had routinely used BCG have discontinued its use.
  • 353
  • 28 Feb 2022
Topic Review
Related Characteristics and Risks of Endometriosis
Endometriosis is one of the most common benign gynecological pathologies, characterized by the presence of heterotopic endometrial mucosa outside the uterine cavity. 
  • 353
  • 27 Jun 2022
Topic Review
Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases
Pulmonary hypertension (PH) is a severe vascular complication of connective tissue diseases (CTD). Patients with CTD may develop PH belonging to diverse groups: (1) pulmonary arterial hypertension (PAH), (2) PH due to left heart disease, (3) secondary PH due to lung disease and/or hypoxia and (4) chronic thromboembolic pulmonary hypertension (CTEPH). PAH most often develops in systemic scleroderma (SSc), mostly in its limited variant. PAH-CTD is a progressive disease characterized by poor prognosis. Therefore, early diagnosis should be established.
  • 352
  • 13 Oct 2023
Topic Review
Biosensor-Integrated Drug Delivery Systems in Diabetes
One of the most recognized diseases worldwide is diabetes. There are currently almost half a billion individuals globally with this disease and this is expected to crest three quarters of a billion by the end of the decade. Traditionally, diabetes is broken into three categories: Type 1 (previously referred to as juvenile); Type 2 (occasion defined as adult onset), and gestational diabetes. Gestational diabetes occurs in ~2–10% of pregnant women with roughly 50% of these cases leading to the mother developing T2D after giving birth. Generally, 5–10% of cases of diabetes are of the T1D form with the remaining 90–95% having T2D. The need to monitor blood glucose, whether for T1D or T2D, is vital for the health and welfare of those afflicted with these diseases. Equally, if not more important, is the need to administer the necessary drug once the knowledge of one’s blood glucose is determined. It is this key second part that has led to significant efforts and ultimate successes in bringing closed-loop systems for diabetes management to market.
  • 351
  • 08 Sep 2022
  • Page
  • of
  • 48
Video Production Service